|
Volumn 47, Issue RR-2, 1998, Pages 1-30
|
Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
VIRUS RNA;
ADULT;
ARTICLE;
CLINICAL TRIAL;
DISEASE TRANSMISSION;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFANT;
ISOLATION AND PURIFICATION;
NEWBORN;
PRACTICE GUIDELINE;
PREGNANCY;
PREGNANCY COMPLICATION;
UNITED STATES;
VIRUS LOAD;
ADULT;
ANTI-HIV AGENTS;
CLINICAL TRIALS;
DISEASE TRANSMISSION, VERTICAL;
FEMALE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
INFANT;
INFANT, NEWBORN;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
REVERSE TRANSCRIPTASE INHIBITORS;
RNA, VIRAL;
UNITED STATES;
VIRAL LOAD;
|
EID: 0032579072
PISSN: 10575987
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (258)
|
References (0)
|